跳至主要内容
临床试验/NCT05484050
NCT05484050Unknown不适用

Estimation of Vascular Endothelial Growth Factor (VEGF) in Iris Tissue in Primary Congenital Glaucoma

Hassan Lotfy Fahmy2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
2
主要终点
VEGF

研究概览

简要总结

Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen in primary congenital glaucoma through Immunohistochemistry.

详细描述

Combined trabeculotomy with mitomycin C will done in infants with primary congenital glaucoma with histopathological examination of the the peripheral iris tissue specimen and vascular endothelial growth factor (VEGF) estimation in iris tissue specimen through Immunohistochemistry.

Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen taking from ocular trauma or congenital cataract used as control.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
1 Day 至 1 Year(Child)
性别
All
接受健康志愿者

入选标准

  • primary congenital glaucoma

排除标准

  • Infants with history of previous surgery.
  • Secondary glaucoma.
  • Glaucoma associated with other congenital anomalies.

结局指标

主要结局

VEGF

时间窗: 6 month

Estimation of VEGF grade in iris tissue through Immunohistochemistry, The grades is arranged from 0 to 5, with 0 being the lowest level and 5 being the highest level

次要结局

未报告次要终点

研究者

发起方
Hassan Lotfy Fahmy
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hassan Lotfy Fahmy

Professor

Assiut University

研究点 (2)

Loading locations...

相似试验

VEGF in Iris Tissue in Primary Congenital Glaucoma | 临床试验